Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026)

Grown Rogue International's (GRUSF) quarterly Cash from Operations came in at 2534524.0 in Q1 2026, up 352.3% year-on-year from 560367.34 in Q1 2025, and up 100.0% quarter-over-quarter from 230723430205.0 in Q4 2025.

Grown Rogue International (GRUSF) Cash from Operations (2013 - 2026) Analysis & Trends

Grown Rogue International's Cash from Operations history runs 14 years deep, the most recent figure standing at 2534524.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 352.3% year-over-year to 2534524.0 in Q1 2026; TTM through Mar 2026 was 230720387069.02, a 7223081.6% decrease from a year earlier, with the FY2025 full-year figure at 3569795.0, up 36.51% from the prior year.
  • Cash from Operations climbed to 2534524.0 in Q1 2026 per GRUSF's latest filing, from 230723430205.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 3586881.17 in Q4 2023 and bottomed at 230723430205.0 in Q4 2025.
  • The 5-year median for Cash from Operations is 1342821.07 (2024), against an average of 19225677966.99.
  • Across the five-year window, Cash from Operations surged 967.93% in 2023 and tumbled 15247565.85% in 2025, its largest moves.
  • Year by year, Cash from Operations stood at 60103.09 in 2022, then soared by 5867.88% to 3586881.17 in 2023, then plunged by 57.81% to 1513191.98 in 2024, then plunged by 15247565.85% to 230723430205.0 in 2025, then jumped by 100.0% to 2534524.0 in 2026.
  • Per Business Quant, the three latest GRUSF Cash from Operations figures stand at 2534524.0 (Q1 2026), 230723430205.0 (Q4 2025), and 1004580.0 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 2.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.53 Mn
Mar 31, 2026 2.53 Mn
Dec 31, 2025 -230.72 Bn
Dec 31, 2025 -230.72 Bn
Mar 31, 2025 -1.00 Mn
Mar 31, 2025 -1.00 Mn
Dec 31, 2024 1.51 Mn
Dec 31, 2024 1.51 Mn
Sep 30, 2024 1.22 Mn
Sep 30, 2024 1.22 Mn
Jun 30, 2024 1.46 Mn
Jun 30, 2024 1.46 Mn
Mar 31, 2024 995,729.65
Mar 31, 2024 995,729.65
Oct 31, 2023 3.59 Mn
Oct 31, 2023 3.59 Mn
Jul 31, 2023 2.82 Mn
Jul 31, 2023 2.82 Mn
Apr 30, 2023 1.46 Mn
Apr 30, 2023 1.46 Mn